|
|
|
|
|
|
FDA panel to review Sanofi's Acomplia in June Mar. 26, 2007 Sanofi-Aventis said on Monday an independent U.S. health expert panel would review its anti-obesity pill Acomplia in June ahead of its possible marketing approval by the U.S. Food and Drug Administration. The French drugmaker said the Endocrinologic and Metabolic Drugs Advisory Committee meeting scheduled for June 13 would discuss the safety and efficacy of Acomplia in obesity. Earlier this year Sanofi announced that the FDA was adding another three months to its period of review for the drug, pushing a decision back to the end of July. Source : Reuters |